Pathology, research and practice
Targeting FOXM1/PSAT1 axis by Brusatol inhibits lung cancer malignant progression.
Siyi Ou, Xiaobo Wang, Yulan Sun, Yongfeng Liang, Jing Bai, Chuanchun Han, Jing Song
Published: 202610.1016/j.prp.2026.156365
Abstract
Brusatol (BRU), an extract from Brucea javanica, has been found to inhibit cancer progression. However, the downstream targets of Brusatol and its underlying mechanisms in lung cancer still not fully elucidate and warrant further investigation. Here,…
Preview only. Read the full abstract at the source